Pfizer shares drop on Chantix research

Wed May 21, 2008 9:39pm BST
 
Email | Print | | Single Page
[-] Text [+]

NEW YORK (Reuters) - Shares of Pfizer Inc (PFE.N: Quote, Profile, Research) fell 1.3 percent in trading after the bell on Wednesday, after U.S. researchers said data showed serious side effects with the company's smoking drug, Chantix.

Shares fell to $19.74 from its close of $20.01 on the New York Stock Exchange.

(Reporting by Kristina Cooke)

 
Currency
US $ inGBP =0.5021
Euro inGBP =0.7879
¥en inGBP =0.0047

Most Popular on Reuters UK